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ABSTRACT
Integrative medicine (IM) is defined as a healing-
oriented medicine that takes account of the whole 
person (body, mind and spirit) including all aspects of 
lifestyle. It emphasises the therapeutic relationship 
and makes use of all appropriate therapies, health-
care professionals and disciplines, in an evidence-
based approach. The IM approach presented here 
considers a different perspective on disease mani-
festations, explores the pathophysiology of allergy in 
the context of biochemical individuality and empha-
sises a systems-oriented approach. Evidence-based 
dietary guidelines, supplements, botanicals and 
mind-body modalities that may be of benefit to the 
allergic patient are presented. 
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INTRODUCTION
The Consortium of Academic Health Centres for Inte-
grative Medicine (CACHIM), defines Integrative Medi-
cine (IM) as ‘the practice of medicine that reaffirms the 
importance of the relationship between practitioner and 
patient, focuses on the whole person, is informed by 
evidence, and makes use of all appropriate therapeutic 
approaches, healthcare professionals and disciplines to 
achieve optimal health and healing.’1 
Across the globe there is evidence of an increased de-
mand for an integrative approach that acknowledges 
complementary and alternative medicine (CAM). De-
teriorating patient-provider relationships, the escalat-
ing costs of conventional medicine, overutilisation of 
pharmaceuticals and technology, and the pandemic of 
chronic disease for which medicine has yet to find ad-
equate solutions, are contributing factors in this trend.2 
Public perception that conventional management of 
chronic conditions is often exclusively reliant on phar-
maceutical measures, while potentially ignoring other 
options which are deemed to be safer, less invasive, 
more natural and more cost-effective, is causing pa-
tients to broaden their healthcare options by going out-
side the conventional healthcare system. Research also 
shows that ‘people find complementary approaches to 
be more aligned with their own values, beliefs, and 
philosophical orientations toward health and life’.2 This 
is borne out by the fact that South African consumers 
spent approximately R3 billion on traditional medicines 
and R4 billion on complementary and alternative medi-
cines, in 2006 alone.3
In the context of all of this, medical practitioners are of-
ten left floundering. Lack of knowledge, limited under-
standing and no regulated forums for proper education 
in the available evidence or effective use of CAM mo-
dalities leaves them without access to relevant infor-
mation, an inability to answer clinical questions and no 
means of effective collaboration with the vast network 
of CAM and traditional medicine (TM) practitioners who 
provide support to their patients. This in turn places 
patients at greater risk of making unsafe treatment 
choices, forgoing necessary conventional treatments 
and receiving inadequate supervision.
Laying the foundations: A note on terminology
The terms allopathic or conventional medicine typi-
cally refer to ‘western’/orthodox medicine as practised 
by the scientifically trained medical doctor in hospitals 
and clinics throughout the world. The term alternative 
medicine usually refers to any treatment, therapy or 
modality that is not recognised by allopathic medicine 
and that patients might use instead of conventional 
medicine. Complementary medicine usually refers to 
any treatment, therapy or modality that may be used in 
conjunction with or as an adjunct to allopathic medicine. 
An example of this would be the use of a herbal medi-
cine (made from herbs) to treat symptoms of nausea 
while a patient is having chemotherapy. It is important 
to understand cultural bias when defining something as 
CAM. For example, to the doctor of Chinese medicine, 
Chinese medicine may be the convention, and anything 
else, including allopathic medicine, might be considered 
alternative or complementary. 
Integrative medicine is not CAM. Neither is it comple-
mentary or alternative to allopathy. On the contrary, IM 
represents a holistic approach to patient care that is 
based on the biopsychosocial framework and is in line 
with current trends in family practice. At the same time, 
it extends beyond the bounds of regular medical prac-
tice to acknowledge different kinds of evidence and in-
corporate methods, treatments and practices from dif-
ferent paradigms in an evidence-based approach. This 
may include functional medicine, lifestyle medicine, 
preventative medicine, and other approaches, along-
side CAM methodology. 
The integrative practitioner
There is a common misconception that IM is the do-
main of CAM practitioners or those ‘misguided’ col-
leagues who operate outside the bounds of ‘proper’ 
science. In fact, good IM practitioners embody the 
ethos of a research-based model by being enquiry-
driven and open to new paradigms. An IM practitioner 
is not defined by the fact that he or she may draw on 
CAM modalities. Rather, IM practitioners are defined 
by their capacity to practise biopsychosocial medicine 
with a strong emphasis on the importance of the thera-
peutic relationship and broader concepts of health and 
wellness, alongside an awareness that the doctor must 
serve as a role model and advocate for health. Practis-
ing IM is less about the tools in the medical toolbox 
and more about a way of being and behaving in rela-
tion to patients. Many CAM practitioners are guilty of a 
mechanistic, reductionist approach that simply replaces 
allopathic drugs with herbs and homeopathic prepara-
tions to manage symptoms. Similarly, many allopathic 
practitioners are practising in a holistic, systems-based, 
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integrative way, without necessarily incorporating CAM 
methods and practices. 
The author’s perspective
In describing the IM perspective on allergies it is not 
the author’s intention to suggest that mainstream ap-
proaches to allergy are not holistic or integrative in na-
ture. Instead, the intention is to offer a perspective that 
might emphasise and reinforce what we already know 
while introducing new concepts that may be useful to 
the primary care practitioner.  
The article therefore provides a brief overview of the in-
tegrative medicine perspective and discusses allergies 
in this context. It also describes some of the therapeu-
tic options for which there is a reliable evidence base. 
Since there is already much literature pertaining to the 
pathophysiology of allergy and conventional allopathic 
treatment, especially of acute and life-threatening aller-
gic manifestations, these will not be the focus of this 
article.
AN INTEGRATIVE PERSPECTIVE 
The biomedical perspective has tended toward a mech-
anistic and reductionist view that seeks to understand 
the underlying cause of disease by way of a linear path 
in which there is a single, underlying initiating cause 
for any pathology. Identifying and treating ‘the cause’ 
becomes the primary therapeutic goal of a pathology-
based, disease-oriented approach. The additional as-
sumption has been that each disease or illness has the 
same, or very similar, underlying cause in every indi-
vidual who exhibits the disease. This resulted in stan-
dardised approaches for treating people with the same 
disease as a collective group, rather than as unique, 
complex individuals displaying similar pathology.  
IM takes a broader stance, which asserts that multiple 
causative factors (genetic, environmental, nutritional, 
physiological, psychological, lifestyle, spiritual, etc.) 
may come together in a particular individual in a particu-
lar way at a particular time to precipitate a particular dis-
ease process. This allows for recognition of biochemical 
and psychosocial individuality (i.e. variations in metabol-
ic function that derive from genetic and environmental 
differences among individuals) and individualised appli-
cation of therapeutic interventions (including biomedi-
cal ones). The causative combination will be unique to 
each individual even though the ultimate manifestation 
might be a similar disease process. 
Health is viewed as a state of dynamic balance between 
internal and external, individual and collective, construc-
tive and destructive forces, that impact on the patient. 
Rather than being ‘caused’ by a morbific agent (e.g. vi-
rus or bacteria or allergen), symptoms of disease are 
the result of the body’s intrinsic response or reaction 
to that morbific agent as it attempts to defend or heal 
itself.4 With this in mind, symptoms and disease are 
not seen as an enemy to be destroyed, but a construc-
tive phenomenon that is the best ‘choice’ the body can 
make to correct an imbalance, given its circumstances. 
Imbalance and susceptibility can occur at multiple lev-
els such as physical, emotional, mental, spiritual, or en-
vironmental, and all of these can express symptomati-
cally through the body. Initially, the signs and symptoms 
of imbalance may be mild and relatively harmless; pro-
longed imbalance will result in more chronic and poten-
tially debilitating dysfunction and disease, as evidenced 
in what has been described as the ‘allergic march’ (the 
progression of allergic disorders from atopic dermati-
tis or eczema to food allergies, allergic rhinitis, and 
allergy-associated asthma which often begins in early 
childhood).5 The physician’s role is to understand and 
support the body in its efforts to restore balance, rather 
than take over or attempt to manipulate the physiology 
of the body – unless the self-healing process has be-
come so exhausted or overwhelmed that it cannot rally 
without external intervention. Suppression of symp-
toms (e.g. inflammation with anti-inflammatories or fe-
ver with antipyretics) or treatment of infection (e.g. with 
antibiotics), without also comprehending and correcting 
the underlying imbalance or unique susceptibility, may 
cause greater distress and disease. 
IM therefore adopts a systems-oriented ‘functional’ ap-
proach that is based on the understanding that complex 
and chronic diseases result from long-term disturbances 
in the normal physiological function of the body. These 
disturbances or core clinical imbalances may be:
•	 	Immune	or	inflammatory	imbalance
•	 	Digestive,	absorptive	or	microbiological	imbalance
•	 	Structural	or	membrane	imbalance
•	 	Hormone	or	neurotransmitter	imbalance
•	 	Detoxification,	 biotransformation	 and	excretory	 im-
balance
•	 	Oxidation/reduction	 or	 homeodynamic	 imbalance	
and mitochondriopathies
•	 	Psychological	and/or	spiritual	imbalance.
Intervening to restore physiological function and prevent 
further disturbances that will result in organ patholo- 
gy and disease progression is considered paramount to 
the prevention of illness and restoration of health. In 
order to do this, practitioners must carefully consider 
how multiple factors interact with and influence the 
physiological function of the individual patient. These 
factors might include:  
•	 	Environmental	inputs,	e.g.	air,	water,	toxic	exposure,	
pollution 
•	 	Lifestyle	choices,	e.g.	diet,	nutrient	intake,	exercise	
habits, sleep patterns
•	 	Mind-body	elements,	e.g.	psychological,	spiritual	and	
social factors
•	 Genetic	make-up.
Treatment plans are customised for each patient and 
focus on interventions that will have the most impact 
on restoring physiological function as a way of promot-
ing, restoring and maintaining health. This may include 
combinations of drugs, therapeutic diets, botanical 
medicines, nutritional supplements, detoxification pro-
grammes, counselling on lifestyle, exercise and stress-
management techniques, as well as incorporation of 
evidence-based TCAM modalities and treatments. Fig-
ure 1 illustrates the functional medicine matrix model 
for mapping the patient’s history and identifying the 
core imbalances that may need to be addressed.
IM AND THE ALLERGIC PATIENT
In South Africa, allergies are more prevalent than TB 
or AIDS, affecting 25-30% of the population and result-
ing in significant morbidity, absenteeism, loss of quality 
of life and even fatal outcomes.6 According to Potter,6 
the term allergy describes a spectrum of diseases and 
variety of reactions whose expression can range from 
mildly debilitating to life-threatening.  The wide range of 
allergic conditions, along with the diversity in end-organ 
effects, give the impression that there are a multitude 
of different mechanisms responsible for allergic symp-
toms.7 However, much of the underlying pathophysiol-
ogy is very similar and the following two phases are 
often involved.6,7
•	 	Induction phase. An initial sensitisation stage, in 
which a genetically susceptible individual develops 
immune memory following allergic sensitisation to 
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an inhaled, ingested or injected substance. During 
this stage the person often has no symptoms of al-
lergy since changes are at the molecular and cellular 
level.
•	  Effector phase. A second, reactivity phase that oc-
curs when the sensitised person is re-exposed to the 
allergen. This re-exposure results in a cascade of re-
actions wherein the mediators of allergic inflamma-
tion produce the observable symptoms of an allergic 
reaction. These can vary from negligible rhinorrhoea 
to severe anaphylaxis and sudden death, depending 
on the degree of exposure and specific sensitivity of 
the individual. Differences in target organ respons-
es will ultimately dictate the clinical syndrome that 
presents once a reaction has been induced.
In addition to managing the end-organ manifestations 
of the allergic response, the integrative practitioner will 
consider measures to diminish the ‘atopic’ predisposi-
tion in each patient, thereby intending to minimise or 
even prevent future recurrence of allergic manifesta-
tions. 
Key considerations that can be discerned from the de-
scription of the two stages include: 
•	 	The	unique	susceptibility	of	individual	patients
•	 	The	 common	 inflammatory	 pathway	 with	 known	
pathophysiology of immune function
•	 	Individual	variation	resulting	in	differing	target	organ	
responses.
The unique susceptibility of individual 
patients
Gene expression is a product of the interaction between 
genetic predisposition and the environment. Allergic ex-
pression is a product of the interaction between genetic 
predisposition, immunity and the environment. Factors 
determining susceptibility are therefore genetic, immu-
nological and environmental. 
In considering environmental factors the IM practitio-
ner will pay attention to aspects over which the patient 
has choice (such as diet, exercise and lifestyle); aspects 
that may be outside the direct control of the individual 
(such as air and water quality, exposure to toxins and 
microbes); aspects that may be the result of unavoid-
able trauma or exposure (such as micro-organisms in 
food); and psychosocial factors (such as stress levels, 
psychospiritual factors, access to resources and socio-
economic status). According to Potter,6 factors typically 
influencing the expression of allergy in Africa include: 
•	 TB/AIDS
•	 Bacterial	and	viral	infections
•	 Parasitic	infectionds
•	 Endotoxin	exposure
•	 Dietary	changes/insufficiencies
•	 Squatter	conditions
•	 Western	lifestyle
•	 Urbanisation/migration.
What is also notable according to Potter, is that rural Af-
ricans who live in the grasslands or deserts of Southern 
Africa in traditional accommodation and follow traditional 
dietary practices rarely suffer from allergic disease, and 
that diseases such as eczema, food allergy and allergic 
rhinitis are rare in rural Africans.6 This is despite the fact 
that traditional dwellings are typically made from clay, 
cow dung and thatch and surrounded by grass pollens, 
wood smoke, chickens, goats, fungal spores and cow 
allergens; theoretically, an ideal environment for the de-
velopment of inhalant and food allergies.6 The so-called 
‘hygiene hypothesis’ also suggests that the reduced 
consumption of fermented foods, prevalent use of anti- 
biotics and increase in hygiene, with its resultant lack 
of exposure to microbial stimulus early in childhood, is 
a major factor for this difference in sensitisation of rural 
versus urban children.8,9 Potter6 cites a study by Stein-
man et al. which revealed an increase in bronchial hy-
perreactivity and specific IgE responsiveness when ru-
ral children adopted a more Western lifestyle; this was 
similar to the prevalence of these conditions in children 
born in the Cape Town suburb of Kirstenhof. Similarly, 
Liu5 asserts that ‘children who grow up in rural areas 
of developing countries or in farming communities are 
several-fold to as much as 50-fold less likely to have 
allergic conditions and to manifest atopic sensitization 
or bronchial hyperresponsiveness when compared with 
children raised in nearby metropolitan areas’. This high-
lights the importance of considering biochemical, as 
well as psychosocial, individuality and the ‘total burden 
of toxicity’ in defining susceptibility.  
Immune function and the inflammatory 
pathway
Allergic responses and reactions are immune-mediated. 
The immune system represents an interface between 
the external and internal environment. In considering in-
tervention for, and prevention of, allergies, 
it is important to understand the progres-
sion of immune dysfunction that typically 
accompanies this range of reactions. Ac-
cording to Liu,5 the development of atopy 
in early childhood is closely associated 
with the later development of allergic dis-
ease. He clarifies that atopy begins when 
the immature immune system develops 
aberrant responses to common, typically 
benign immunogens, whether environ-
mental or endogenous. Chronic, ongoing 
exposure then exacerbates and prolongs 
injury and inflammation to the airways, re-
sulting in abnormal repair of affected tis-
sues. If this process begins in early child-
hood and continues through the stages 
of lung growth and differentiation, then 
the adult lung in such a person may differ 
from the normal lung, potentially describ-
ing the persistent asthma phenotype.5
Healthy development of the immune sys-
tem relies on protective type 1 helper T-
cell (Th1) immune responses to naturally 
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occurring infections and microbial exposures of the re-
spiratory and gastrointestinal tracts, which begin imme-
diately after birth. Th1-based immunity also prevents 
pro-allergic type 2 helper T-cell (Th2) immune develop-
ment and atopy and improves host defence, thereby 
preventing environmental exposure from precipitating 
allergic manifestations.5 Th1 responses during airway 
injury and inflammation also inhibit abnormal repair pro-
cesses that underlie pathological tissue changes in asth-
ma.5 According to Michail,9 there is increasing evidence 
to suggest that environmental factors and aberrant gut 
microflora are associated with a shift of the Th1/Th2 
balance towards a Th2 response in allergic disorders, 
although the exact aetiology remains unclear.
Postulated immunological modifiers of expression of 
atopic diseases include:6
•	 	Early	 exposure	 to	 lipopolysaccharide/endotoxins	
which induce Th1 responses
•	 	Parasite	 induction	 of	 interleukin-10	 (IL-10)	 produc-
tion via Th2 cells
•	 	Tolerance	 induced	by	heavy	allergen	exposure	 (es-
pecially via the oral route)
•	 	Exposure	to	minute	doses	of	allergen	in	‘clean’	envi-
ronments tends to ‘sensitise’.
Individual variation in target organ re-
sponse
Immune function is inextricably interconnected not only 
with external, environmental influences, but also with 
internal, multiple-system function. The endocrine sys-
tem, gastrointestinal system, nervous system and nu-
tritional status are intricately associated with immune 
health. A systems approach is therefore imperative 
when contemplating suitable interventions and preven-
tative measures for allergic responses.
PREVENTION AND INTERVENTION
Nutrition
Food allergies and atopic dermatitis may precede and 
predict the development of allergic rhinitis and asth-
ma.5 The severity of atopic disorders is predictive of 
their persistence and progression.5 This suggests that 
dietary intervention, particularly in childhood, may be a 
vital part of management of the allergic patient. Food 
allergies are increasingly common in the primary care 
setting.10 Practitioners distinguish between food aller-
gies caused by a distinct immunological reaction (such 
as IgE-mediated anaphylactic reaction to peanuts or 
shellfish) and purported food sensitivity and/or intoler-
ance, which appears to be a more common complaint 
in general practice. Food intolerance is defined as a re-
producible adverse reaction to a specific food or group 
of foods without a clearly identifiable immune mecha-
nism.10 Exaggerated reactions to a digestive product 
of a particular food, impairment of the intestinal barrier 
function (also known as ‘leaky gut syndrome’), gen-
eralised and immunoglobulin G (IgG)-mediated inflam-
matory reactions have all been postulated as possible 
mechanisms.10,11 Symptoms may range from the ab-
dominal discomfort of lactose intolerance and irritable 
bowel syndrome, to worsening of arthritic symptoms 
in response to wheat-containing foods.10 Heightened 
awareness and clinical suspicion should alert the prac-
titioner to the possibility of food sensitivity or intoler-
ance, especially in patients with chronic and recurring 
symptomatology.10 In particular, dairy products, animal 
proteins and wheat have been popularly linked to aller-
gic exacerbations and worsening of allergic symptoms 
in many patients.7 According to Enrique et al.12 several 
studies have also documented cases of cross-reactivity 
between food and pollen antigens. 
Modified elimination or low allergen diets form the 
mainstay of diagnosis and even treatment in an integra-
tive approach. Common antigens such as wheat and 
dairy, or select antigens identified by the history, are 
removed from the diet for a period of 4-6 weeks with 
appropriate support to ensure optimum nutrition. Dur-
ing this time the patient is observed for an improve-
ment in symptoms and supported with an array of other 
measures designed to reduce inflammation and restore 
healthy gastrointestinal and systemic function. Impli-
cated foods may then be re-introduced with 2-4-day 
intervals, allowing for possible delayed hypersensitivity 
reactions to be observed. If these occur then the of-
fending food should be eliminated entirely in the case 
of true allergy, or for a period of 3-6 months in the case 
of sensitivities and intolerance, after which it may be 
re-introduced again.
Basic dietary guidelines for allergic patients 
These include:7,10,13
•	  Use plant proteins instead of animal proteins as 
far as possible since animal proteins include high 
levels of arachidonic acid (AA) which may be inher-
ently pro-inflammatory7,14-16 in action. Elmadfa and 
Kornsteiner14 cite research by Dimopoulos and by 
Das which shows that prostanoids (prostaglandins, 
prostacyclins, thromboxanes), leukotrienes, lipoxins, 
and resolvins released from dihomo-linolenic acid 
(DGLA), AA, eicosapentaenoic acid (EPA), and doco-
sahexaenoic acid (DHA) have a key role in modulat-
ing inflammation, cytokine formation, immune re-
sponse, platelet aggregation, vascular reactivity and 
thrombosis. In particular, studies have focused on 
the role of AA metabolites as mediators of inflamma-
tion in various conditions, including asthma.14-16 AA 
produces prostaglandin E2 (PGE2) and thus raises 
cardinal signs of inflammation, including fever, vas-
cular permeability and vasodilatation, and enhances 
pain and oedema caused by other agents such as 
bradykinin and histamine.14 AA also induces throm-
boxane A2 (a powerful platelet aggregator and va-
soconstrictor) as well as prostacyclin 12 (vasodilator 
and inhibitor of platelet aggregation).14 In addition, 
leukotriene B4 (LTB4), which is a potent inducer of 
inflammation, leucocyte chemotaxis and adherence, 
is produced via lipoxygenase from AA.14 Conversely, 
investigations have also demonstrated that PGE2 in-
hibits lipoxygenase thereby reducing the formation 
of LTB4 and encouraging the formation of lipoxins, 
which have anti-inflammatory effects.14 
•	 	Avoid or eliminate milk and dairy products. 
•	  Eliminate wheat and other gluten-containing 
products.
•	  Increase intake of natural antioxidants by increas-
ing intake of fruits and vegetables. Although this is 
a subject of much debate and controversy, various 
studies have suggested that increased dietary con-
sumption of vitamin C and selenium, in particular, as 
well as vitamin E and vitamin B6, may reduce allergic 
manifestations and asthma prevalence.13 Hassed13 
also cites some evidence that a vegan exclusion diet 
with high fluid intake may lead to significant improve-
ment in symptoms, although this may be due to the 
high intake of fruits and vegetables.
•	 	Eliminate polyunsaturated vegetable oils, par-
tially hydrogenated oils and all foods that may 
contain trans-fatty acids (e.g. fried foods). These 
were shown to double the risk of asthma and poten-
tially contribute to 17% of asthma cases in children 
aged 3-5 years in a survey conducted by Haby et al., 
cited by Hassed,13 among children in New South 
Wales.
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•	 	Increase intake of omega-3 essential fatty 
acids. These have been shown to decrease the ratio 
of omega-6 to omega-3 fatty acids in the fatty acid 
composition of cell membranes, resulting in less 
substrate for inflammatory mediator production.7,14 
Elmadfa and Kornsteiner cite research by Dimopou-
los and by Calder which indicate that decreased pro-
duction of AA-derived mediators can be achieved by 
fish oil consumption, leading to postulation that fatty 
fish has anti-inflammatory effects and may be useful 
in the prevention and therapy of inflammatory con-
ditions. An Australian study by Hodge et al., cited 
by Hassed,13 found that children who ate fish once 
a week reduced their chance of developing asthma 
by one-third compared to those who ate no fish, al-
though evidence for clinical effect of omega-3 sup-
plements in asthma is still unconvincing. 
Gastrointestinal health
The mucosal surface of the gastrointestinal system 
acts not only as a portal and barrier to the entry of in-
gested substances, but also as an organ of immune 
surveillance, detoxification and neuro-endocrine modu-
lation. Seventy per cent of immune cells occur in the 
gut-associated lymphoid tissue (GALT).17 The ability of 
the body to maintain healthy gastrointestinal function, 
and to repair the mucosal barrier is therefore integral 
to protection from many diseases and disorders. Re-
search also suggests that commensal flora may play a 
role in immune regulation, depending on the specific 
antigen, intestinal permeability, degree of inflammation, 
and maturation of the GALT, particularly in early infancy. 
Hanaway17 cites Kelly & Coutts, who postulate that in-
creased prevalence of formula feeding and subsequent 
loss of critical immunological factors present in breast 
milk have contributed to the increased incidence of al-
lergy and asthma. This is further borne out by evidence 
that encouragement of prolonged breastfeeding, spe-
cifically in children whose mothers do not have allergic 
disease, has a protective effect.6,11
The ‘4R’ programme is advocated by many IM practi-
tioners as a critical component of management to opti-
mise gastrointestinal function: 11
•	  Remove potentially antigenic foods and additives 
with a modified elimination diet and eradicate patho-
genic bacteria, fungi and parasites with appropriate 
drugs and/or botanicals. Blood tests for food aller-
gens, e.g. radio-allergosorbent test (RAST), followed 
by specific IgE may be useful only where a specific 
allergen is suspected. Stool analysis may identify rel-
evant pathogens. 
•  Replace critical digestive enzymes (such as proteas-
es, lipases, cellulases) and other digestive factors 
which may be lacking or limited. Gastric analyses, 
fat absorption tests and stool analysis may verify 
the need to replace enzymes and other digestive 
factors.11 Plant-based formulas containing digestive 
enzymes are readily available. 
•	 	Re-inoculate with probiotics to re-establish micro- 
floral balance. According to Michail,9 probiotics have 
been shown to modulate the immune system back 
to a Th1 response, and several in vitro studies have 
suggested a role for probiotics in treating allergic 
disorders.8,9,18 At the same time, Michail9 also points 
out that human trials demonstrate some limited ben-
efit for the use of probiotics in atopic dermatitis, less 
robust data for benefit in the use of allergic rhinitis, 
and no role in the treatment of bronchial asthma.9 A 
study by Taylor et al.18 concluded that early probiotic 
supplementation with Lactobacillus acidophilus did 
not reduce the risk of atopic dermatitis in high-risk 
infants and was, in fact, associated with increased al-
lergen sensitisation in infants receiving supplements. 
Kalliomäki et al.8 point out that choice of probiotic 
strain, widely variable dosages, timing of interven-
tions, and  differing trial designs are important factors 
in reviewing the evidence, and provide numerous 
guidelines for further studies.9 Anecdotal experience 
does however suggest that probiotic supplementa-
tion may be of benefit to patients and future studies 
may substantiate this. Various commercial prepara-
tions are available and IM practitioners will usually 
prescribe either a blend of several bacteria, or partic-
ular strains of bacteria for different ailments, depend-
ing on their particular clinical experience. 
•	  Repair by providing nutritional support for regen-
eration and healing of the gastrointestinal mucosa. 
Nutrients that may be valuable in mucosal cell dif-
ferentiation, growth, functioning and repair, include 
glutamine, essential fatty acids (omega-3), zinc and 
pantothenic acid.11 
Detoxification
The body’s complex detoxification systems function 
to minimise potential damage from exogenous and 
endogenous sources. It therefore follows that optimal 
functioning of the organs (liver, kidneys, lungs, skin and 
intestines) and pathways (lymph, blood, bile, extracel-
lular matrix) of elimination may be essential to the man-
agement of most chronic diseases, since overload or 
imbalance is likely to aggravate and perpetuate chronic 
illness. It is recognised that diet and lifestyle choices 
can influence the level of exposure to potentially tox-
ic substances, as well as detoxification function, and 
various mechanisms for this have been described.19,20 
Experts continue to debate the validity of evidence for 
detoxification procedures. Emerging science does how-
ever support various links between nutrition and de-
toxification, therefore diet forms the mainstay of treat-
ment.19 Regular exercise, massage, sauna, and various 
nutritional supplements and herbs may purportedly be 
of benefit to the ‘toxic’ patient.20
Supplements 
•	 	Quercetin is a bioflavonoid found in apples, buck-
wheat, onions, and citrus fruits which, according to 
Otsuka et al., cited by Horwitz,7 and others, appears 
to stabilise the membranes of mast cells and reduce 
the release of preformed histamine in vitro.7 Ac-
cording to Horwitz,7 quercetin is commonly recom-
mended for use during the allergy season, or even 
year-round for those with perennial allergies, since 
its action appears to be  primarily preventative in na-
ture.7 He recommends a dose of 400-600 mg of a 
coated tabled 1-3 times daily between meals. This 
dose may be adjusted according to clinical response. 
No specific precautions or contraindications apply.7
•	  Magnesium is often a routine standard of care in 
the emergency treatment of asthma, because of 
its anti-inflammatory properties and relaxant effect 
on smooth muscle. Some published reports note 
an improvement in asthma symptoms in patients 
with higher magnesium intake.7,11 Low-dose supple-
ments (400 mg of  magnesium glycinate) may have 
a role to play in the management of asthma.7,11
•	 	Other	nutritional	supplementation	such	as	vitamin	C	
(500-1000 mg), selenium, glutamine, zinc, pantoth-
enic acid and omega-3 fatty acids, as well as probiot-
ics, may be of value as indicated earlier in the text. 
Botanicals
•	  Stinging nettle (Urtica dioica) has apparently been 
used as an anti-allergy preparation by some IM prac-
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titioners for many years.7 The ‘hair’ and leaves of this 
plant apparently contain histamine, serotonin, acetyl-
choline and 5-hydroxytryptamine compounds, which 
are associated with allergic manifestations.7 Various 
theories have been proposed for its antihistaminic 
properties7 and one randomised, double-blind study 
found that 57% of patients rated it effective in reliev-
ing allergic rhinitis symptoms, while 48% said that it 
equalled or surpassed previously used allergy medi-
cations in its effectiveness.7 Recommended dos-
age is usually 300-350 mg of a freeze-dried extract 
used 1-3 times per day, or as needed. Rare allergic 
reactions and possible mild gastrointestinal irritation 
have been reported.7
•	  Other herbs that look promising based on a review 
of various trials, include garlic, dried ivy leaf extract, 
gingko biloba, ephedra, boswellia, some Ayurvedic 
Indian herbs (e.g. Albizia and Coleus) and thyme ex-
tract.7 Herbs such as slippery elm, fenugreek, devil’s 
claw, angelica sinensis and licorice, purportedly also 
have antioxidant and anti-inflammatory properties. 
Herbal medicines can have interactions with phar-
maceutical drugs and should only be prescribed by 
appropriately trained practitioners.
Mind-body therapies
Numerous studies document the value of mind-body 
approaches to many allergic conditions.2,7,13,18 Lehrer’s 
review of 185 references (cited by Hassed13) conclud-
ed that panic and negative emotions affect asthma, 
producing hyperventilation, increased autonomic labil-
ity, autonomic arousal, bronchoconstriction, and poor 
health behaviours.13 Family stress and a range of psy-
chosocial factors are predictive factors in increased like-
lihood of genetic disposition to asthma and paediatric 
asthma deaths.13 Stress, via increased serum cortisol, 
is considered pro-inflammatory and stress reduction 
through techniques such as meditation and yoga may 
help to decrease the frequency and intensity of allergic 
reactions.13,21 Relaxation techniques such as breathing 
exercises have been associated with positive effects 
on inflammatory illnesses including asthma and rheu-
matoid arthritis.13 According to Hassed,13 yoga breath-
ing exercises, when taught by a trained yoga therapist, 
have been associated with significantly less asthma 
attacks per week, improved scores for drug treatment 
and improved lung function. Hassed13 also cites evi-
dence that biofeedback and hypnotherapy have been 
associated, in some reviews, with reduced hospital ad-
missions and reduced need for prednisolone. A meta-
analysis by Devine, cited by Hassed,13 revealed that 
psycho-education (education, behavioural skills, cogni-
tive therapy and counselling) reduced asthma attacks 
and was associated with better lung function, adher-
ence to treatment, utilisation of health care, psychologi-
cal wellbeing and use of medication.13
Other
•	 	Standard	recommendations	are	to	reduce	exposure	
to mould, pollen, dust mites, dander and other envi-
ronmental allergens.
•	 	Neti	 pots,	 small	 ‘teapot-like’	 devices	 available	 in	
health stores, are purportedly excellent for use as 
saline irrigators. This removes particle allergens from 
sensitive mucous membranes and has been shown 
to decrease the inflammatory mediators histamine 
and leukotriene C4.22
•	 	Anecdotal	evidence	suggests	a	place	for	chiropractic,	
homeopathy, massage, biochemical tissue salts, and 
qigong in the management of asthma and allergies.13 
Further rigorous studies are needed to confirm these 
results.
CONCLUSION
The emphasis on recognising fundamental clinical im-
balances and optimising physiological function to ad-
dress chronic and inflammatory disease is a valuable 
addition to a disease-oriented, pathology-based ap-
proach. The importance of nutrition and the supportive 
role of supplements, herbs and mind-body approaches 
advocated by the IM approach have much to offer the 
primary care practitioner, particularly with regard to the 
way management of chronic disease is perceived.
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